Global Market Study on Allergy Shots: Increasing Prevalence of Allergic Rhinitis Supporting Market Growth


Allergy Shots  Market
  • Published On : Sep-2020 |
  • Pages : 309 Pages |
  • Format : Allergy Shots  Market Allergy Shots  Market Allergy Shots  Market Allergy Shots  Market

Globally, the prevalence of various types of allergies is on the rise due to increased levels of pollution, and changing lifestyles and dietary habits, which is leading to the growth of the global allergy shots market. The most common type of allergy is allergic rhinitis, often known as hay fever, caused due to particles in the air such as dust mites, pollen, etc. Globally, the prevalence of allergic rhinitis is registered at around 35%. Along with that, food allergy is also highly prevalent and affects more than 10% of adult population, globally, each year.

Growing cases of allergic disorders is increasing the need for more specific and convenient treatments, which, in turn, is driving the expansion of the allergy shots market size.

Allergy Shots Market Trends

Rising Demand for Sublingual Tablets (SLIT) Supporting Market Growth: The treatment for an allergy is lengthy and can take 3-5 years for a complete course. Patients undergoing treatment usually discontinue the process midway due to prolonged treatment time. However, development of SLIT has made treatment easy and convenient. The use of SLIT potentially improves the compliance of allergen shots and makes allergy treatment more accessible and well-tolerated.

Leading companies in the allergy shots market are focusing on development and launch of SLIT drugs. SLIT has been shown to be an effective treatment for airway allergies, atopic dermatitis, and food allergy, and recent studies suggest the use of SLIT as the first choice for allergy treatment as compared to other medications and SCIT. Detailed analysis of some of the most popular SLIT drugs, including Odactra, Grastek, Ragwitek, Oralair, and Actair, has been provided PMR’s allergy shots market report.

Increasing Focus on Developing Oral Immunotherapy Products Presents Lucrative Opportunities for Allergy Shots Market: Oral immunotherapies (OITs) are primarily focused on hay fever and food allergy. Globally, growing prevalence of food allergy and hay fever/allergic rhinitis is gaining the attraction of manufacturers to develop specific treatments for them. OITs can potentially decrease the risk for severe allergic reactions due to accidental or unintentional allergen exposure. As of now, Palforzia by Aimmune Therapeutics is the only oral immunotherapy product approved for food allergy. This can offer new growth opportunities for the allergy shots market.

Risk of Adverse Effects of SCIT & SLIT Can Hamper Market Growth: The allergy shots market can experience a decline due to the adverse effects associated with allergy shots and tablets. For instance, more than 1.5% of patients administered Oralair experience adverse effects such as respiratory, gastrointestinal, or skin-related disorders. Also, rarely, a serious systemic reaction called anaphylaxis can develop. These side effects associated with the treatment may hinder the growth of the allergy shots market.

COVID-19 Impact on Allergy Shots Market

The global outbreak of COVID-19 has led to lockdowns, shutdowns, and trade restrictions. A majority of developed countries have postponed non-essential medical procedures, as focus is clearly on COVID-19 patients. The impact on SLIT has been minimum, as these tablets and drops are self-administered at home. However, new patient initiation has been limited. On the other hand, subcutaneous therapies (SCIT) have been most impacted, since they are typically administered at clinics. These factors are expected to impede the growth of the allergy shots market in the near term.

Analysts’ Viewpoint

An extensive analysis of the allergy shots market has brought our analysts to a conclusion that, the market is growing at a significant rate. Currently, sublingual immunotherapy (SLIT) is the target segment for major healthcare facilities, and hence, this segment is anticipated to gain more traction in the allergy shots market in term of market growth. Europe and North America collectively hold more than 65% of allergy shots market revenue share, due to the presence of key manufacturers in the region. Emerging countries such as Brazil, China, and India are expected to offer lucrative opportunities for players in the allergy shots market. The MEA region will also witness augmented growth, owing to the rising prevalence of allergies and entry of leading market players in the region.

Allergy Shots Market - Scope of the Report

The latest publication by Persistence Market Research (PMR) on the global allergy shots market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global allergy shots market. The study offers detailed insights on key market dynamics, which includes the drivers, restraints, trends, and opportunities in the allergy shots market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030. 

Important indicators for the successful growth of the allergy shots market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market and compounded annual growth rate (CAGR. This research study can support readers to know the demand for allergy shots and quantitative development opportunities during the study period.

The research is beneficial for shareholders in the allergy shots industry, including allergy shots market investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the allergy shots market. Insights and wisdom presented in this PMR study can be leveraged by shareholders in the allergy shots market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.  

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the allergy shots market are also included in the current study. Depending on potential developments in the allergy shots market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this allergy shots market report, minor companies and new entrants in the allergy shots industry can be aided in making suitable company choices to achieve traction in the allergy shots market.  

Key Segments of Allergy Shots Market

PMR’s study on the allergy shots market offers information divided into six important segments — product, immunotherapy, indication, allergan, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product

  • SLIT Tablets
  • Oral
  • Injections
  • Others

Immunotherapy

  • Sublingual Immunotherapy
  • Subcutaneous Immunotherapy
  • Others

Indication

  • Allergic Rhinitis
  • Allergic Asthma
  • Food Allergy
  • Atopic Dermatitis
  • Others

Allergan

  • Pollens
  • House Dust Mites (HDM)
  • Mould
  • Animal Dander
  • Bee Venom
  • Cockroaches/Insects
  • Others

Distribution Channel

  • Institutional Sales
    • Government Hospitals
    • Semi-government Hospitals
    • Private Hospitals
  • Retail Sales

Region

  • North America
  • Latin America
  • Europe.
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

 Key Questions Answered in PMR’s Allergy Shots Market Report

  • Which regions will continue to remain the most profitable regional markets for allergy shots market players?
  • Which factors will induce a change in the demand for allergy shots during the assessment period?
  • How will changing trends impact the allergy shots market?
  • How can market players capture the low-hanging opportunities in the allergy shots market in developed regions?
  • What are the winning strategies of stakeholders in the allergy shots market to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and might tackle while investing in the allergy shots market?
  • What are the developmental trends in allergy shots sectors that will impact the market?
  • How can businesses in the allergy shots market avail the growth opportunities in developed and emerging sectors?

Allergy Shots Market: Research Methodology

In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the allergy shots market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the allergy shots market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the allergy shots market, and makes PMR’s projections on the growth prospects of the allergy shots market more accurate and reliable.

Companies covered in Allergy Shots Market Report

  • ALK Abello
  • Stallergenes Greer
  • Allergy Therapeutics
  • Aimmune Therapeutics
  • Anergis
  • Arrayit Corporation
  • Biomay AG
  • HAL Allergy Group
  • DBV Technologies
Back To Top